Abiomed
ABMD
#1305
Rank
NZ$30.45 B
Marketcap
NZ$675.43
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Earnings for Abiomed (ABMD)

Earnings in 2022 (TTM): NZ$0.55 Billion

According to Abiomed's latest financial reports the company's current earnings are NZ$1.07 Billion. In 2021 the company made an earning of NZ$0.33 Billion a decrease over its 2020 earnings that were of NZ$0.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Abiomed from 2013 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) NZ$0.55 B64.06%
2021 NZ$0.33 B-25.49%
2020 NZ$0.45 B-19.62%
2019 NZ$0.56 B48.14%
2018 NZ$0.37 B51%
2017 NZ$0.25 B71.85%
2016 NZ$0.14 B41.79%
2015 NZ$0.10 B187.69%
2014 NZ$35.72 M126.26%
2013 NZ$15.79 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
NZ$6.63 B 996.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Teleflex
TFX
NZ$0.22 B-63.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
-NZ$7.6 Million-101.26%๐Ÿ‡บ๐Ÿ‡ธ USA